News & Press

Starting sevelamer may reduce mortality risk among hemodialysis patients

Starting sevelamer may reduce mortality risk among hemodialysis patients

People with end-stage renal disease often have abnormally high levels of phosphorus in their blood, which raises their risk of cardiovascular disease and mortality. Calcium-based phosphate binders have been the standard treatment for many years, but a newer treatment, sevelamer hydrochloride or sevelamer carbonate, is becoming increasingly common as an add-on or alternative therapy.

Expansion of the DOPPS Practice Monitor to the Gulf Cooperation Council Countries

Expansion of the DOPPS Practice Monitor to the Gulf Cooperation Council Countries

The Dialysis Outcomes and Practice Patterns Study (DOPPS) is expanding the DOPPS Practice Monitor (DPM) to display hemodialysis data for the Gulf Cooperation Council (GCC) countries: Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates.

The DOPPS Program marks its 20th anniversary with an overview of major findings

The DOPPS Program marks its 20th anniversary with an overview of major findings

The DOPPS is celebrating its 20-year anniversary of uncovering new clinically useful information for the practicing nephrologist. In a new paper, investigators provide an overview of major findings and comment on the analytical approaches used.

Nephrology clinics in the US can join the CKDopps

Nephrology clinics in the US can join the CKDopps

The CKDopps is seeking nephrology clinics in the United States to join our study of variations in advanced chronic kidney disease (CKD) treatment practices and associations with best outcomes for patients.

Outcomes for hemodialysis patients with hepatitis C infection

Outcomes for hemodialysis patients with hepatitis C infection

Hepatitis C virus (HCV) infection is common among hemodialysis patients worldwide. Although guidelines recommend treatment of all patients infected with HCV, it is rarely treated in hemodialysis patients. In a recent paper, investigators evaluated the burden of HCV infection among hemodialysis patients.

Interdialytic weight gain and patient outcomes in the DOPPS

Interdialytic weight gain and patient outcomes in the DOPPS

High interdialytic weight gain (IDWG) is associated with adverse outcomes in hemodialysis patients. In a recent paper published in the American Journal of Kidney Diseases, researchers used data from the DOPPS to identify trends in IDWG, predictors of IDWG, and associations of IDWG with clinical outcomes.